Skip to main content
Download PDF

Erratum to: Concentration of antibodies against Porphyromonas gingivalisis increased before the onset of symptoms of rheumatoid arthritis

Arthritis Research & Therapy volume 18, Article number: 257 (2016) Cite this article

The Original Article was published on 07 September 2016

Erratum

Unfortunately, after publication of this article [1], it was noticed that the x-axis markers for Fig. 2a and b were incorrect. The corrected figure can be seen below.

Fig. 2
figure 1

Antibody responses during the pre-dating time until the time point for onset of symptoms of RA, from pre-symptomatic individuals who donated multiple blood samples pre-dating the onset of symptoms of RA (n = 422) and from patients with RA (n = 192). Logarithmic mean concentrations during 2-year periods of anti-RgpB and anti-CPP3 antibodies in pre-symptomatic individuals, patients with RA and controls (n = 198) (a). Accumulated percentages of antibody positivity for anti-CPP3, anti-CCP2, anti-cfibrinogenβ36-52 (cFibβ36-52), anti-CEP-1 (α-enolase) and anti-cfilaggrin (cFilaggrin) antibodies in pre-symptomatic individuals and in patients with RA (b). 0 time point for onset of RA symptoms

Full size image

Reference

  1. Johansson L, Sherina N, Kharlamova N, Potempa B, Larsson B, Israelsson L, Potempa J, Rantapää-Dahlqvist S, Lundberg K. Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis. Arthritis Res Ther. 2016;18:201. doi:10.1186/s13075-016-1100-4.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden

      Linda Johansson & Solbritt Rantapää-Dahlqvist

    2. Department of Medicine Solna, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden

      Natalia Sherina, Nastya Kharlamova, Barbro Larsson, Lena Israelsson & Karin Lundberg

    3. Department of Oral Immunology and Infectious Diseases, University of Louisville, School of Dentistry, Louisville, KY, USA

      Barbara Potempa & Jan Potempa

    4. Department of Microbiology, and Malopolska Centre of Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland

      Jan Potempa

    Authors
    1. Linda Johansson
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Natalia Sherina
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Nastya Kharlamova
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Barbara Potempa
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Barbro Larsson
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Lena Israelsson
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Jan Potempa
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Solbritt Rantapää-Dahlqvist
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Karin Lundberg
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Solbritt Rantapää-Dahlqvist.

    Additional information

    The online version of the original article can be found under doi:10.1186/s13075-016-1100-4.

    Rights and permissions

    Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Johansson, L., Sherina, N., Kharlamova, N. et al. Erratum to: Concentration of antibodies against Porphyromonas gingivalisis increased before the onset of symptoms of rheumatoid arthritis. Arthritis Res Ther 18, 257 (2016). https://doi.org/10.1186/s13075-016-1164-1

    Download citation

    • Received:

    • Accepted:

    • Published:

    • DOI: https://doi.org/10.1186/s13075-016-1164-1

    Arthritis Research & Therapy

    ISSN: 1478-6362

    Contact us